Madrigal Pharmaceuticals Inc (MDGL)
EBITDA Margin
-22.75%
TTM · Period ending:
MDGL EBITDA Margin
Latest reported-22.75%period ending
Latest reported-22.75%period ending
MDGL TTM EBITDA Margin (-44446.24% → -22.75%)
TTM ebitda margin
High-resolution chart · PNG
MDGL ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -22.748% | |
| -24.8208% | |
| -27.5948% | |
| -36.4735% | |
| -51.7398% | |
| -118.5164% | |
| -249.8843% | |
| -654.3827% | |
| -3,380.0041% | |
| -1,093.5861% | |
| -995.7375% | |
| -887.8042% | |
| -793.8159% | |
| -1,472.3529% | |
| -956.4769% | |
| -725.1973% | |
| -579.7468% | |
| -511.3686% | |
| -401.4521% | |
| -308.2194% | |
| -236.2021% | |
| -217.0659% | |
| 66.2619% | |
| 66.196% | |
| 57.1243% | |
| 45.4212% | |
| -724.7289% | |
| -1,221.377% | |
| -1,984.9695% | |
| -1,732.5091% | |
| -2,050.8336% | |
| -3,095.4829% | |
| -8,460.8345% | |
| -44,446.2428% |